Skip NavigationSkip to Content
Evidence Needed to Support the Clinical Utility of Molecular Diagnostics
January 10-11, 2013
Top Right Header
Spacer image Spacer
Spacer Evidence Needed to Support the Clinical Utility of Molecular Diagnostics

Evidence Needed to Support the Clinical Utility of Molecular Diagnostics

January 10-11, 2013
Natcher Auditorium (Building 45)
NIH-Bethesda
REGISTRATION NOW OPEN!

Many decisions for cancer patient management depend on information derived from clinical laboratory tests in addition to that derived from the clinical evaluation of these patients. At this workshop, participants will discuss and debate the definition of clinical utility for oncologic treatment, the evidence needed to demonstrate clinical utility for a molecular diagnostic, how that evidence should be obtained, and how NCI can best assist in the demonstration of clinical utility in the context of clinical trials. NCI will use this workshop to inform decisions about its role in this endeavor. The workshop format will be primarily interactive, with most of the time devoted to small focused breakout discussion groups. Please review the materials for your chosen breakout session under the Breakout Session Materials tab on this website before arriving at the workshop.

General Information

For conference related questions please contact Julia Lam
301-228-4141

Location


Natcher Auditorium
Building 45
NIH-Bethesda

Spacer Image
Bottom Conference Border